Skip to main content
Log in

ASO Visual Abstract: Prognostic Impact of the Loss of Skeletal Muscle Mass during Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsuya Tsuji MD, PhD.

Ethics declarations

Tsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, Yu Koishihara, Nobuko Konishi, Nanako Hijikata, Aiko Ishikawa, Daisuke Kotani, Takashi Kojima, Hisashi Fujiwara, and Takeo Fujita declare no potential conflicts of interest with regard to the research, authorship, or publication of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harada, T., Tsuji, T., Ueno, J. et al. ASO Visual Abstract: Prognostic Impact of the Loss of Skeletal Muscle Mass during Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer. Ann Surg Oncol 29, 8142–8143 (2022). https://doi.org/10.1245/s10434-022-12401-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12401-7

Navigation